Sayenko Kharenko has helped AbbVie Inc. obtain merger clearance from the Anti-Monopoly Committee of Ukraine for its global USD 63 billion acquisition of Allergan plc.
AbbVie is a research-based global biopharmaceutical company that is, Sayenkp Kharenko reports, "committed to developing innovative, advanced therapies for some of the world’s most complex and critical conditions.”
Allergan is a manufacturer of pharmaceuticals that operates in more than 100 countries.
Sayenko Kharenko’s team included Partner Valentyna Hvozd, Senior Associate Anastasia Bodnar, and Associate Snizhanna Savka.
Editor's note: After this article was published, Prica & Partners informed CEE Legal Matters that it had acted as Serbian advisor to AbbVie on the deal. The firm's team was led by Partner Tijana Lalic.